IVAX Pharmaceuticals UK, Ltd. ,   United Kingdom

Glucocorticosteroid for topical application
Suspension for inhalation dosage 0.25 mg / ml; 0.5 mg / ml.
Bronchodilator combined (beta2-adrenomimetic selective + m-holinoblokator)

Solution for inhalation, 0.2 mg + 1 mg / ml.

M-holinoblokator

Solution for inhalation, 0.25 mg / ml.

Immunomodulating agent

A solution for subcutaneous administration of 20 mg / ml.

Immunomodulating agent
A solution for subcutaneous administration is 40 mg / ml.
Bronchodilator - beta2-adrenomimetic is selective.
Solution for inhalation 1 mg / ml, 2 mg / ml.